Atai Life Sciences Total Liabilities 2020-2025 | ATAI

Atai Life Sciences total liabilities from 2020 to 2025. Total liabilities can be defined as the total value of all possible claims against the corporation.
Atai Life Sciences Annual Total Liabilities
(Millions of US $)
2024 $43
2023 $49
2022 $40
2021 $28
2020 $16
2019 $2
Atai Life Sciences Quarterly Total Liabilities
(Millions of US $)
2025-03-31 $44
2024-12-31 $43
2024-09-30 $51
2024-06-30 $47
2024-03-31 $46
2023-12-31 $49
2023-09-30 $40
2023-06-30 $38
2023-03-31 $40
2022-12-31 $40
2022-09-30 $47
2022-06-30 $29
2022-03-31 $29
2021-12-31 $28
2021-09-30 $21
2021-06-30 $21
2021-03-31 $25
2020-12-31 $16
2020-09-30 $0
2020-06-30 $0
2020-03-31 $0
2019-12-31 $2
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $0.437B $0.000B
atai Life Sciences B.V. is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. atai Life Sciences B.V. is based in BERLIN.
Stock Name Country Market Cap PE Ratio
Quest Diagnostics (DGX) United States $19.987B 19.70
Encompass Health (EHC) United States $12.114B 25.68
DaVita (DVA) United States $10.370B 14.58
Chemed (CHE) United States $8.164B 25.66
Elanco Animal Health (ELAN) United States $7.037B 15.07
Option Care Health (OPCH) United States $5.219B 23.26
RadNet (RDNT) United States $4.245B 269.43
Amedisys (AMED) United States $3.191B 21.46
LifeStance Health (LFST) United States $2.108B 0.00
Addus HomeCare (ADUS) United States $2.098B 23.04
Astrana Health (ASTH) United States $1.477B 36.60
U.S Physical Therapy (USPH) United States $1.187B 30.64
Aveanna Healthcare Holdings (AVAH) United States $0.991B 56.44
Pennant (PNTG) United States $0.956B 35.11
MEDIROM Healthcare Technologies (MRM) Japan $0.047B 0.00
Daxor (DXR) United States $0.043B 0.00
Ontrak (OTRK) United States $0.006B 0.00
Psychemedics (PMD) United States $0.000B 0.00